Biodegradable implant can deliver targeted cancer immunotherapy while protecting healthy tissue

Scientists at Houston Methodist Research Institute have developed a biodegradable implant designed to deliver cancer-fighting immunotherapy drugs directly into tumors over an extended period, a strategy that could improve treatment effectiveness while reducing side effects.

Originally published at Phys.org